{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-105024","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2024-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.846312+00:00","generated_at":"2026-05-30T23:03:12.727180+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"CytoSorbents authorizes up to $20M ATM equity offering of common stock","bullets":["Company authorized offer and sale of up to $20M common stock under Open Market Sale Agreement with Jefferies LLC.","Registration statement on Form S-3 (No. 333-281062) declared effective by SEC on September 30, 2024.","Legal opinion of Morgan Lewis & Bockius LLP on legality of issuance filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-105024","json":"https://secwatch.observer/filing/0001104659-24-105024.json","markdown":"https://secwatch.observer/filing/0001104659-24-105024.md","text":"https://secwatch.observer/filing/0001104659-24-105024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000110465924105024/0001104659-24-105024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000110465924105024/tm2425360d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T23:03:12.727180+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}